Things didn’t go efficiently: The initial rollout was marked by 8 “crucial” severity defects, 47 significant-severity defects, and A huge number of supplemental difficulties recorded all through an extended period of “go-Stay hypercare.” By March 2017 the venture had long gone so far south that MillerCoors sued HCL for $one hundred millio